Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

18F-FDG PET/CT: an unexpected case of Huntington's disease.

Michels S, Buchholz HG, Rosar F, Heinrich I, Hoffmann MA, Schweiger S, Tüscher O, Schreckenberger M.

BMC Neurol. 2019 May 1;19(1):78. doi: 10.1186/s12883-019-1311-9.

2.

Striatal hypometabolism in premanifest and manifest Huntington's disease patients.

López-Mora DA, Camacho V, Pérez-Pérez J, Martínez-Horta S, Fernández A, Sampedro F, Montes A, Lozano-Martínez GA, Gómez-Anson B, Kulisevsky J, Carrió I.

Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2183-2189. Epub 2016 Jun 28.

PMID:
27349245
3.

Cortical atrophic-hypometabolic dissociation in the transition from premanifest to early-stage Huntington's disease.

Sampedro F, Martínez-Horta S, Perez-Perez J, Horta-Barba A, Lopez-Mora DA, Camacho V, Fernández-León A, Gomez-Anson B, Carrió I, Kulisevsky J.

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1111-1116. doi: 10.1007/s00259-018-4257-z. Epub 2019 Jan 9.

PMID:
30627816
4.

Structural and metabolic brain correlates of apathy in Huntington's disease.

Martínez-Horta S, Perez-Perez J, Sampedro F, Pagonabarraga J, Horta-Barba A, Carceller-Sindreu M, Gomez-Anson B, Lozano-Martinez GA, Lopez-Mora DA, Camacho V, Fernández-León A, Carrió I, Kulisevsky J.

Mov Disord. 2018 Jul;33(7):1151-1159. doi: 10.1002/mds.27395. Epub 2018 Apr 20.

PMID:
29676484
5.

Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease.

Agosta F, Altomare D, Festari C, Orini S, Gandolfo F, Boccardi M, Arbizu J, Bouwman F, Drzezga A, Nestor P, Nobili F, Walker Z, Pagani M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1546-1556. doi: 10.1007/s00259-018-4033-0. Epub 2018 May 1. Review.

PMID:
29717332
6.

Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.

Feigin A, Leenders KL, Moeller JR, Missimer J, Kuenig G, Spetsieris P, Antonini A, Eidelberg D.

J Nucl Med. 2001 Nov;42(11):1591-5.

7.

Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.

Caminiti SP, Sala A, Iaccarino L, Beretta L, Pilotto A, Gianolli L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D.

Alzheimers Res Ther. 2019 Feb 23;11(1):20. doi: 10.1186/s13195-019-0473-4.

8.

[Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].

Banzo I, Quirce R, Martínez-Rodríguez I, Jiménez-Bonilla J, Portilla-Quattrociocchi H, Medina-Quiroz P, Ortega F, Rodríguez E, Mateo I, Vázquez-Higuera JL, de Arcocha M, Carril JM.

Rev Esp Med Nucl. 2011 Sep-Oct;30(5):301-6. doi: 10.1016/j.remn.2011.03.010. Epub 2011 Jun 2. Spanish.

9.

More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.

Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.

PMID:
30843003
10.

Functional connectivity modeling of consistent cortico-striatal degeneration in Huntington's disease.

Dogan I, Eickhoff CR, Fox PT, Laird AR, Schulz JB, Eickhoff SB, Reetz K.

Neuroimage Clin. 2015 Feb 27;7:640-52. doi: 10.1016/j.nicl.2015.02.018. eCollection 2015.

11.

Molecular Imaging Markers to Track Huntington's Disease Pathology.

Wilson H, De Micco R, Niccolini F, Politis M.

Front Neurol. 2017 Jan 30;8:11. doi: 10.3389/fneur.2017.00011. eCollection 2017. Review.

12.

Amyloid imaging with (11)C-PIB PET/CT and glucose metabolism with (18)F-FDG PET/CT in a study on cognitive impairment in the clinical setting.

Banzo I, Jiménez-Bonilla J, Ortega-Nava F, Quirce R, Martínez-Rodríguez I, de Arcocha-Torres M, Rodríguez E, Vázquez JL, Sánchez PJ, Martínez-Amador N, Ibañez-Bravo S, Carril JM.

Nucl Med Commun. 2014 Mar;35(3):238-44. doi: 10.1097/MNM.0000000000000042.

PMID:
24240196
13.

Decreased Metabolism in the Cerebral Cortex in Early-Stage Huntington's Disease: A Possible Biomarker of Disease Progression?

Shin H, Kim MH, Lee SJ, Lee KH, Kim MJ, Kim JS, Cho JW.

J Clin Neurol. 2013 Jan;9(1):21-5. doi: 10.3988/jcn.2013.9.1.21. Epub 2013 Jan 3.

14.

Functional neuroimaging using F-18 FDG PET/CT in amnestic mild cognitive impairment: A preliminary study.

Tripathi M, Tripathi M, Sharma R, Jaimini A, Md'souza M, Saw S, Mondal A, Kushwaha S.

Indian J Nucl Med. 2013 Jul;28(3):129-33. doi: 10.4103/0972-3919.119538.

15.

Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease.

Novak MJ, Warren JD, Henley SM, Draganski B, Frackowiak RS, Tabrizi SJ.

Brain. 2012 Apr;135(Pt 4):1165-79. doi: 10.1093/brain/aws024.

16.

Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease.

Herben-Dekker M, van Oostrom JC, Roos RA, Jurgens CK, Witjes-Ané MN, Kremer HP, Leenders KL, Spikman JM.

J Neurol. 2014 Jul;261(7):1387-97. doi: 10.1007/s00415-014-7350-7. Epub 2014 Apr 30.

PMID:
24781835
17.

Acetylcholinesterase inhibitors in cognitive impairment in Huntington's disease: A brief review.

Vattakatuchery JJ, Kurien R.

World J Psychiatry. 2013 Sep 22;3(3):62-4. doi: 10.5498/wjp.v3.i3.62.

18.

Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.

Cerami C, Della Rosa PA, Magnani G, Santangelo R, Marcone A, Cappa SF, Perani D.

Neuroimage Clin. 2014 Dec 5;7:187-94. doi: 10.1016/j.nicl.2014.12.004. eCollection 2015.

19.

Striatal neural grafting improves cortical metabolism in Huntington's disease patients.

Gaura V, Bachoud-Lévi AC, Ribeiro MJ, Nguyen JP, Frouin V, Baudic S, Brugières P, Mangin JF, Boissé MF, Palfi S, Cesaro P, Samson Y, Hantraye P, Peschanski M, Remy P.

Brain. 2004 Jan;127(Pt 1):65-72. Epub 2003 Nov 7.

PMID:
14607797
20.

Increased brain tissue sodium concentration in Huntington's Disease - a sodium imaging study at 4 T.

Reetz K, Romanzetti S, Dogan I, Saß C, Werner CJ, Schiefer J, Schulz JB, Shah NJ.

Neuroimage. 2012 Oct 15;63(1):517-24. doi: 10.1016/j.neuroimage.2012.07.009. Epub 2012 Jul 14.

PMID:
22796981

Supplemental Content

Support Center